AML Hematology MSL – Southeast Territory

IQVIA; Miami (FL); Sur place; USD 170 000 - 210 000; Plein temps

Résumé du poste

IQVIA is seeking experienced Medical Science Liaisons to support a late-stage AML program. The MSL will engage investigators, hematologists, oncologists, and other healthcare professionals to facilitate scientific exchange and gather insights on disease biology, MRD, and evolving standards of care.

The role requires advanced clinical or scientific training and 4+ years in MSL or relevant medical affairs with hematology/oncology expertise.

Qualifications

• MSL experience in hematology/oncology or clinical development science.

Responsabilités

• Develop and maintain scientific relationships with investigators and hematology/oncology leaders.
• Engage in peer-to-peer scientific discussions on AML, MRD, and evolving standards of care.
• Communicate complex clinical data clearly to diverse external stakeholders.
• Support medical education programs, advisory boards, and investigator meetings.
• Identify educational needs and provide investigators with study development support.
• Maintain clinical expertise through conferences and literature review.
• Collaborate with Medical Affairs leadership to execute field medical plans.

Connaissances

MSL experience in hematology/oncology

Excellent communication to diverse HCP

Travel up to 70%

CRM and MS Office proficiency

Independent yet collaborative

Formation

Advanced clinical or scientific degree (PharmD/MD/DO/PhD/DNP/NP/PA)

Outils

CRM platforms

Microsoft Office Suite

Microsoft Teams

Description du poste

IQVIA is seeking experienced Medical Science Liaisons to support a late-stage AML program. The MSL will engage investigators, hematologists, oncologists, and other healthcare professionals to facilitate scientific exchange and gather insights on disease biology, MRD, and evolving standards of care.

The role requires advanced clinical or scientific training and 4+ years in MSL or relevant medical affairs with hematology/oncology expertise.